SARS-CoV-2 Spike-derived Peptide (YNYKLPDDFTGCVIA)
Antibody screening, T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, Cellular immune response
| ￥960 | |
| RP30231 | |
|
|
|
|
|
|
|
|
|
| ￥960 | |
| RP30231 | |
|
|
|
|
|
|
|
|
|
| Description | Antibody screening, T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, Cellular immune response |
| Sequence |
{Tyr}{Asn}{Tyr}{Lys}{Leu}{Pro}{Asp}{Asp}{Phe}{Thr}{Gly}{Cys} {Val}{Ile}{Ala} |
| Sequence Shortening | YNYKLPDDFTGCVIA |
| Molecular Weight | 1718.93 |
| Purity | >95% |
| Solubility | Soluble in dimethyl sulfoxide(Analytical grade) under 1mg/ml |
| Form | Lyophilized |
| Storage | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
